Epoulosis Therapeutics Inc.

Newton, MA

UEI
XQLHBLT82YR5
CAGE
99XV8
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
508 Dudley Rd #107, Newton, MA 02459, USA
Website
epoulosisrx.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Epoulosis Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Metrifonate local application for DFU treatment - diabetic foot ulceration (DFU) is a major problem in diabetic patients… Grant · R44DK141401 National Institute of Diabetes and Digestive and Kidney Diseases $3,062,212

Quick answers

What is Epoulosis Therapeutics Inc.'s UEI?

Epoulosis Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is XQLHBLT82YR5.

What is Epoulosis Therapeutics Inc.'s CAGE code?

Epoulosis Therapeutics Inc.'s CAGE code is 99XV8.

What is Epoulosis Therapeutics Inc.'s primary NAICS code?

Epoulosis Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Epoulosis Therapeutics Inc. located?

Epoulosis Therapeutics Inc.'s physical address in SAM.gov is 508 Dudley Rd #107, Newton, MA 02459, USA.

Is Epoulosis Therapeutics Inc. registered in SAM.gov?

Yes. Epoulosis Therapeutics Inc.'s SAM.gov registration is active through June 23, 2027.

What is Epoulosis Therapeutics Inc.'s most recent federal award?

Epoulosis Therapeutics Inc.'s most recent federal grant award is Metrifonate local application for DFU treatment - diabetic foot ulceration (DFU) is a major problem in diabetic patients… (R44DK141401), from National Institute of Diabetes and Digestive and Kidney Diseases, on August 1, 2025.

On GovTribe

See Epoulosis Therapeutics Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login